111In-bleomycin imaging of breast tumours
- PMID: 6156836
- DOI: 10.1007/BF00445624
111In-bleomycin imaging of breast tumours
Abstract
Forty female patients with 15 malignant breast tumours and 25 benign growths, all verified histologically, were studied before surgery using mammography and 111In-Bleomycin scintigraphy. The patient was studied lying prone on a table with an opening so that one breast could hang in front of the gamma camera. The true positive and negative scintigraphy results are slightly poorer (70%) than the mammography results (80%) and there are more false negative scintigraphy interpretations mostly in small lesions.
Similar articles
-
111Indium-bleomycin breast and axilla imaging.Cancer. 1976 Jan;37(1):36-42. doi: 10.1002/1097-0142(197601)37:1<36::aid-cncr2820370106>3.0.co;2-a. Cancer. 1976. PMID: 55300
-
Comparison of 67Ga-citrate, 111In-bleomycin and 99mTc-citrate in the evaluation of pulmonary lesions.Eur J Nucl Med. 1980;5(1):57-61. doi: 10.1007/BF00261208. Eur J Nucl Med. 1980. PMID: 6155268
-
Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast.Mayo Clin Proc. 2005 Jan;80(1):24-30. doi: 10.1016/S0025-6196(11)62953-4. Mayo Clin Proc. 2005. PMID: 15667025
-
[Breast scintigraphy].Rev Esp Med Nucl. 2001 Feb;20(1):47-70. Rev Esp Med Nucl. 2001. PMID: 11181333 Review. Spanish. No abstract available.
-
Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.Clin Endocrinol (Oxf). 1998 Nov;49(5):685-9. doi: 10.1046/j.1365-2265.1998.00527.x. Clin Endocrinol (Oxf). 1998. PMID: 10197087 Review.
Cited by
-
Stability of 111In-bleomycin in vivo--properties compared with 57Co-bleomycin.Eur J Nucl Med. 1983;8(12):535-40. doi: 10.1007/BF00251616. Eur J Nucl Med. 1983. PMID: 6199207
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical